Health TrialsbyHealthPanel

Obstructive Sleep Apnea and Body Awareness

ConditionObstructive Sleep Apnea (OSAS)
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18-65
SponsorKarabuk University

About this trial

Obstructive Sleep Apnea Syndrome (OSAS) is a chronic disease characterized by intermittent hypoxia and sleep fragmentation resulting from recurrent upper airway obstructions. The physiological and neurocognitive changes caused by the disease can affect how individuals perceive and interpret bodily sensations. Although body awareness plays a significant role in the perception and management of symptoms, its relationship with clinical parameters in individuals with OSAS has not been sufficiently investigated. Therefore, the aim of our study is to examine the relationship between body awareness and respiratory function, disease severity, fatigue, shortness of breath, and sleep quality in OSAS patients.

Eligibility criteria

This trial accepts healthy volunteers

Qualifiers

Receiving a diagnosis of OSA after polysomnography,

Having an Apnea-Hypopnea Index ≥5 for OSA,

Volunteering to participate in the study.

Disqualifiers

Having severe orthopedic, neurological, or cardiac diseases,

Having a diagnosed lung disease,

Having a previous or current history of psychiatric or neurological disorders,

Not voluntarily participating in the study.

Trial population

Patients with obstructive sleep apnea syndrome

Trial design

Design model

Case-only

Time perspective

Cross-sectional

Treatments tested in this trial

Not listed

Trial groups

47 Participants
are grouped into 1 trial group
Group A: Obstructive Sleep Apnea Syndrome Group

Trial outcomes

Primary outcomes

1

Body awareness

The Body Awareness Questionnaire (BAQ) will be used to assess individuals' body awareness. The scale score ranges from 18 to 26, with higher scores indicating higher awareness.

Time frame
Baseline
2

Dyspnea

Dyspnea is assessed with the modified Medical Research Council (mMRC) dyspnea scale. As the score increases, shortness of breath increases.

Time frame
Baseline
3

Disease severity

The evaluation will be based on the Apnea/Hypopnea index measured by polysomnography. An Apnea-Hypopnea Index \>5 indicates Obstructive Sleep Apnea Syndrome.

Time frame
Baseline
4

Fatigue severity

Fatigue will be assessed using the Fatigue Severity Scale. A score of 36 or higher indicates severe fatigue.

Time frame
Baseline

Secondary outcomes

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

Karabuk University

Lead sponsor

Source ClinicalTrials.gov
Apply now